North America is the most mature POC CT market, with a value share of roughly 38 percent in 2024 and a CAGR near 5.0 percent. The United States dominates this region, supported by emergency department congestion, a large number of primary stroke centers, and reimbursement pathways for portable CT in hospital outpatient settings. Canada is following with slower but steady adoption, while Mexico shows demand in private hospital groups with US-style trauma protocols.
Asia Pacific is the fastest-growing regional market, with a value share of about 26 percent and a projected CAGR of approximately 7.0 percent. China, India, and Indonesia account for most incremental volume because their acute care systems are expanding rapidly. Chinese OEMs are also creating an indigenous supply chain for compact X-ray tubes and detectors, reducing landed costs and accelerating domestic adoption. Japan and South Korea remain high-quality but slower-growing markets because of aging infrastructure and stricter radiation regulations.
Europe holds a 24 percent share, with Germany, the UK, and France as the primary demand centers. European adoption is shaped by the EU Medical Device Regulation, which adds complexity for new entrants, and by national radiation protection frameworks that vary across countries. The Nordic region has integrated compact CT into mobile stroke unit trials, while Italy and Spain show interest but face slower public hospital budget cycles.
South America and the Middle East & Africa together make up approximately 12 percent of the market. Brazil is the largest Latin American buyer, largely due to private emergency hospital networks, and Turkey and the GCC states are the leading Middle East markets. These regions are attractive because installed fixed CT density is low, but high tariffs, currency volatility, and service logistics limit faster growth. Overall, North America remains the most mature market, while Asia Pacific, specifically China and India, will generate the steepest growth over the forecast period.